Perry C. Siatis - 25 Feb 2026 Form 4 Insider Report for AbbVie Inc. (ABBV)

Role
EVP, GC AND SECRETARY
Signature
/s/ T.O. Odutayo, Attorney-in-Fact for Perry C. Siatis
Issuer symbol
ABBV
Transactions as of
25 Feb 2026
Net transactions value
-$5,147,630
Form type
4
Filing time
27 Feb 2026, 17:00:05 UTC
Previous filing
20 Feb 2026
Next filing
03 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Siatis Perry C EVP, GC AND SECRETARY 1 N. WAUKEGAN ROAD, NORTH CHICAGO /s/ T.O. Odutayo, Attorney-in-Fact for Perry C. Siatis 27 Feb 2026 0001951400

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABBV Common Stock, $0.01 par value Options Exercise $1,094,321 +7,314 +19% $149.62 45,451 25 Feb 2026 Direct
transaction ABBV Common Stock, $0.01 par value Options Exercise $1,362,802 +7,775 +17% $175.28 53,226 25 Feb 2026 Direct
transaction ABBV Common Stock, $0.01 par value Options Exercise $1,406,335 +7,292 +14% $192.86 60,518 25 Feb 2026 Direct
transaction ABBV Common Stock, $0.01 par value Sale $5,147,630 -22,381 -37% $230.00 38,137 25 Feb 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABBV Option (Right to buy) Options Exercise $1,094,321 -7,314 -100% $149.62 0 25 Feb 2026 Common Stock 7,314 $149.62 Direct F1
transaction ABBV Option (Right to buy) Options Exercise $1,362,802 -7,775 -50% $175.28 7,774 25 Feb 2026 Common Stock 7,775 $175.28 Direct F2
transaction ABBV Option (Right to buy) Options Exercise $1,406,335 -7,292 -33% $192.86 14,583 25 Feb 2026 Common Stock 7,292 $192.86 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable in annual increments of 7,315 on February 16, 2024, 7,315 on February 16, 2025, and 7,314 on February 16, 2026.
F2 Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable in annual increments of 7,775 on February 15, 2025 and 7,775 on February 15, 2026, and becomes exercisable as to 7,774 shares on February 15, 2027.
F3 Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable as to 7,292 shares on February 13, 2026 and becomes exercisable in annual increments of 7,292 on February 13, 2027, and 7,291 on February 13, 2028.